P08.44 Phase II study of hypofractionated radiation therapy with concomitant and adjuvant temozolomide following surgical resection for patients with newly diagnosed glioblastoma: preliminary evaluation

INTRODUCTION: The current standard treatment for glioblastoma multiforme (GBM) has led a median, overall survival (OS) of 14.6 months, a 2-year progression-free survival (PFS) of 11% and a 2-year OS of 27.2%. The predominantly local failure pattern indicates the need to intensify local treatment. Ra...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Navarria, P., Pessina, F., Ascolese, A., Tomatis, S., Bello, L., Simonelli, M., Riva, M., Lopci, E., Santoro, A., Scorsetti, M.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
P08 Glioblastom and Anaplastic gliomas
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5782673/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.177
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki